Product Information
BALSALAZIDE DISODIUM 750 MG CP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.3443 per EA under NDC 00054007928. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054007928
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BALSALAZIDE DISODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA077806FDA Approved
12/28/2007
TE Code
AB
On Market Since
12/28/2007
Pharmacological Classes
Price Statistics
The NADAC for BALSALAZIDE DISODIUM 750 MG CP has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 53.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3443 per EA |
|---|---|
| All-time high | $0.5827 (Mar 11, 2015) |
| All-time low | $0.2245 (Nov 28, 2013) |
| 52-week high | $0.4113 |
| 52-week low | $0.3443 |
| Median price | $0.4259 |
| Average price | $0.4273 |
| Largest weekly change | +99.5% (Mar 19, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Balsalazide Disodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminosalicylate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BALSALAZIDE DISODIUM 750 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BALSALAZIDE DISODIUM 750 MG CP, manufactured by Hikma Pharmaceuticals USA Inc., is $0.3443 per EA (NDC 00054007928), effective Sep 30, 2026.
How has the price of BALSALAZIDE DISODIUM 750 MG CP changed over time?
Over the history we have for it, the NADAC for BALSALAZIDE DISODIUM 750 MG CP has risen 53.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BALSALAZIDE DISODIUM 750 MG CP?
Since Nov 28, 2013, the NADAC for BALSALAZIDE DISODIUM 750 MG CP has ranged from a low of $0.2245 (Nov 28, 2013) to a high of $0.5827 (Mar 11, 2015), with a median of $0.4259 per EA.
Are there cheaper alternatives to BALSALAZIDE DISODIUM 750 MG CP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BALSALAZIDE DISODIUM 750 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures BALSALAZIDE DISODIUM 750 MG CP?
BALSALAZIDE DISODIUM 750 MG CP (NDC 00054007928) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.